CSU gets $3 million health grant to help develop new drugs

CLEVELAND - There is big money on the way for Cleveland State University, with the school announcing two grants from the National Institutes of Health, totaling $3 million.

The money will be used by CSU professors to research and develop new anti-inflammatory and anticoagulant drugs.

Associate Professor Barsanjit Mazumder received $1.75 million to continue research on his discovery of a new mechanism that controls inflammation. Further research from this grant will help develop a new generation of drugs that could safely block the progression of inflammatory diseases, such as cardiovascular disease and arthritis.

Associate Professor Xue-Long Sun received $1.25 million to develop anticoagulants that are safer for stroke and heart attack victims. Anticoagulants have been identified as one of the top five drug types associated with patient safety incidents in the United States. Sun's development will work toward reducing many dangers associated with the drugs, such as excessive bleeding.